Exploring the Causal Relationship Between Telomere Biology and Alzheimer’s Disease

Abstract

Telomeres, also known as the “protective caps” of our chromosomes, shorten with each cell cycle due to the end replication problem. This process, termed telomere attrition, is associated with many age-related disorders, such as Alzheimer’s disease (AD). Despite the numerous studies conducted in this field, the role of telomere attrition in the onset of the disease remains unclear. To investigate the causal relationship between short telomeres and AD, this review aims to highlight the primary factors that regulate telomere length and maintain its integrity, with an additional outlook on the role of oxidative stress, which is commonly associated with aging and molecular damage. Although some findings thus far might be contradictory, telomere attrition likely plays a crucial role in the progression of AD due to its close association with oxidative stress. The currently available treatments for AD are only symptomatic without affecting the progression of the disease. The components of telomere biology discussed in this paper have previously been studied as an alternative treatment option for several diseases and have exhibited promising in vitro and in vivo results. Hence, this should provide a basis for future research to develop a potential therapeutic strategy for AD. Graphical Abstract (Created with BioRender.com)

Mendelian randomization evidence based on European ancestry for the causal effects of leukocyte telomere length on prostate cancer

“…Seven of the 23 candidate mediators met the screening criteria and were included in subsequent MR analysis. In terms of Alzheimer’s disease, although the results of inversive MR indicated a genetically determined impact on LTL, we inferred that this effect was caused by an underlying negative feedback mechanism, and that Alzheimer’s disease is still a potential mediator of LTL-mediated PCs rather than a possible confounding factor [ 71 ].…”

Why Does the Antioxidant Complex Twendee X® Prevent Dementia?

“…Telomere length is considered a biological marker of age, and telomeres shorten as cells divide during the aging process [ 48 ]. Recent reports have suggested that telomere shortening is a potential factor in the development of aging-related diseases and AD [ 49 , 50 , 51 ] and that shorter telomeres tend to be present in dementia patients [ 52 ].…”

Molecular Determinants of Neurocognitive Deficits in Glioma: Based on 2021 WHO Classification

“…More direct evidence comes from Emily Schroeder et al’s study ( 2016 ), which illustrated in patients with bipolar I disorder that reduced BRAF protein expression in olfactory neuroepithelial progenitor cells (ONPs) can induce apoptosis via the MEK/ERK signaling pathway. Previous studies have demonstrated that TERT may protect against Alzheimer’s disease (AD) by lowering levels of reactive oxygen species (ROS) and preventing oxidative harm (Kuan et al 2023 ). Furthermore, it has been discovered that in mouse models, TERT maintenance leads to the enhancement of the gene network responsible for controlling synaptic signaling and learning processes, which are significant for the preservation of cognitive functions (Shim et al 2021 ).…”